Capsaicin inhibits proliferation of endometriotic cells in vitro

Gynecologic and Obstetric Investigation

Volumn 66, Issue 1, 2008, Pages 59-62

  Wu, Yan ^a   Starzinski Powitz, Anna ^b   Guo, Sun Wei ^c  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Capsaicin; Endometriosis; Inhibition; Pain; Proliferation

Indexed keywords

CAPSAICIN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIOSIS; ENDOMETRIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

CAPSAICIN; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GROWTH INHIBITORS; HUMANS;

EID: 47549106342     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000124275     Document Type: Article

References (30)

1. Giudice LC, Kao LC: Endometriosis. Lancet 2004;364:1789-1799.
2. Wheeler JM, Malinak LR: Recurrent endometriosis: incidence, management, and prognosis. Am J Obstet Gynecol 1983;146:247-253.
3. Waller KG, Shaw RW: Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 1993;59:511-515.
4. Kiilholma P, Tuimala R, Kivinen S, Korhonen M, Hagman E: Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril 1995;64:903-908.
5. Lessey BA: Medical management of endometriosis and infertility. Fertil Steril 2000;73:1089-1096.
6. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, et al: Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005;57:359-383.
7. Nothnick WB, D'Hooghe TM: Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes. Gynecol Obstet Invest 2003;55:189-198.
8. Fedele L, Berlanda N: Emerging drugs for endometriosis. Expert Opin Emerg Drugs 2004;9:167-177.
9. Monsereenusorn Y, Kongsamut S, Pezalla PD: Capsaicin: a literature survey. Crit Rev Toxicol 1982;10:321-339.
10. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ: Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004;328:991.
11. Hail N Jr, Lotan R: Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J Natl Cancer Inst 2002;94:1281-1292.
12. Kim CS, Park WH, Park JY, Kang JH, Kim MO, Kawada T, et al: Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food 2004;7:267-273.
13. Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M, et al: Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 2006;66:3222-3229.
14. Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, et al: Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res 2004;64:1071-1078.
15. Surh YJ: More than spice: capsaicin in hot chili peppers makes tumor cells commit suicide. J Natl Cancer Inst 2002;94:1263-1265.
16. Morre DJ, Chueh PJ, Morre DM: Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA 1995;92:1831-1835.
17. Park JY, Kawada T, Han IS, Kim BS, Goto T, Takahashi N, et al: Capsaicin inhibits the production of tumor necrosis factor alpha by LPS-stimulated murine macrophages, RAW 264.7: a PPARgamma ligand-like action as a novel mechanism. FEBS Lett 2004;572:266-270.
18. Singh S, Natarajan K, Aggarwal BB: Capsaicin (8-methyl-N-vanillyl-6- nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol 1996;157:4412-4420.
19. Guo SW: Nuclear factor-kappaB (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obestet Invest 2006;63:71-97.
20. Gonzàlez-Ramos R, Donnez J, Defrère S, et al: Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod 2007;13:503-509.
21. Krikun G, Mor G, Alvero A, et al: A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 2004;145:2291-2296.
22. Zeitvogel A, Baumann R, Starzinski-Powitz A: Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol 2001;159:1839-1852.
23. Wu Y, Guo SW: Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780. Gynecol Obstet Invest 2006;62:193-205.
24. Gonzalez-Ramos R, Donnez J, Defrere S, et al: Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod 2007;13:503-509.
25. Reilly CA, Yost GS: Metabolism of capsaicinoids by P450 enzymes: a review of recent findings on reaction mechanisms, bio-activation, and detoxification processes. Drug Metab Rev 2006;38:685-706.
26. Immke DC, Gavva NR: The TRPV1 receptor and nociception. Semin Cell Dev Biol 2006;17:582-591.
27. Kissin EY, Freitas CF, Kissin I: The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis. Anesth Analg 2005;101:1433-1439.
28. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, et al: Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA 1997;94:6535-6540.
29. Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, et al: Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 2001;84:1424-1431.
30. Voskoglou-Nomikos T, Pater JL, Seymour L: Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 2003;9:4227-4239.